Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study

Ralph T. H. Leijenaar, Marta Bogowicz, Arthur Jochems, Frank J. P. Hoebers, Frederik W. R. Wesseling, Sophie H. Huang, Biu Chan, John N. Waldron, Brian O'Sullivan, Derek Rietveld, C. Rene Leemans, Ruud H. Brakenhoff, Oliver Riesterer, Stephanie Tanadini-Lang, Matthias Guckenberger, Kristian Ikenberg, Philippe Lambin

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number2017049811075
Number of pages8
JournalBritish Journal of Radiology
Volume91
Issue number1086
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • SQUAMOUS-CELL CARCINOMA
  • OROPHARYNGEAL CANCER
  • HUMAN-PAPILLOMAVIRUS
  • TEXTURE ANALYSIS
  • NECK-CANCER
  • HEAD
  • FEATURES
  • PARAMETERS
  • SELECTION
  • MEDICINE

Cite this

Leijenaar, R. T. H., Bogowicz, M., Jochems, A., Hoebers, F. J. P., Wesseling, F. W. R., Huang, S. H., Chan, B., Waldron, J. N., O'Sullivan, B., Rietveld, D., Leemans, C. R., Brakenhoff, R. H., Riesterer, O., Tanadini-Lang, S., Guckenberger, M., Ikenberg, K., & Lambin, P. (2018). Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study. British Journal of Radiology, 91(1086), [2017049811075]. https://doi.org/10.1259/bjr.20170498